Back to search

Poland· PL-100453519

Efferalgan Codeine

A codein, kombinationen exkl. psycholeptika (codein monopräparate siehe r05da04) product containing paracetamolum + codeini phosphas hemihydricus, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 3 of our 19 countries.

ATC N02AA59

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedEfferalgan CodeineATCN02AA59REGISTER NO.PL-100453519PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Codein, kombinationen exkl. psycholeptika (codein monopräparate siehe r05da04) is registered in 3 of 19 countries.

Countries holding a registration under ATC N02AA59 (codein, kombinationen exkl. psycholeptika (codein monopräparate siehe r05da04)), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Codein, kombinationen exkl. psycholeptika (codein monopräparate siehe r05da04) · ATC N02AA59

3 / 19 countries

  • Belgiumprice
  • Canada
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Paracetamolum + Codeini phosphas hemihydricus
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
N02AA59
ATC class
Codein, Kombinationen exkl. Psycholeptika (Codein Monopräparate siehe R05DA04)
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991456337

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for codein, kombinationen exkl. psycholeptika (codein monopräparate siehe r05da04).

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Codein, kombinationen exkl. psycholeptika (codein monopräparate siehe r05da04) · interactions on record

4 records

4 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Codein, kombinationen exkl. psycholeptika (codein monopräparate siehe r05da04) in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All codein, kombinationen exkl. psycholeptika (codein monopräparate siehe r05da04) products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Belgium · Algocod, Dafalgan
  • Cyprus · Parcoten
  • Czechia · Korylan, Talvosilen Forte
  • Germany · Azur Compositum Sc, Paracetamol Al Comp.
  • Denmark · Kodipar, Pinex Comp
  • Estonia · Algocalm, Paracetamol/Codeine Accord
  • Spain · Analgiplus, Cod-Efferalgan
  • Finland · Panacod, Paracetamol/Codeine Accord
  • France · Claradol Codeine, Codoliprane
  • United Kingdom (Northern Ireland) · Co-Codamol, Co-Codamol Accord-Uk
  • Greece · Lonalgal
  • Hungary · Parcodin, Talvosilen Forte
  • Ireland · Co-Codamol, Co-Tipol
  • Iceland · Parkódín, Parkódín Forte
  • Italy · Co Efferalgan, Codamol
  • Lithuania · Cocodamol, Cocodamol Actavis
  • Luxembourg · Algocod, Dafalgan
  • Latvia · Co-Codamol Actavis, Paracetamol/Codeine Accord
  • Malta · Codipar, Parcoten
  • Netherlands · Paracetamol/Codeïne Eurogenerics, Paracetamol/Codeïnefosfaat Accord
  • Norway · Altermol, Paracetamol / Codeine Phosphate Hemihydrate Accord
  • Portugal · Dol-U-Ron, Dol-U-Ron Forte
  • Romania · Paradoren, Ultracod
  • Sweden · Altermol, Citodon
  • Slovakia · Korylan, Paramax-Cod

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bd3839fc-c334-47a9-b35f-54ce62f5bf99
GET /v1/drugs/bd3839fc-c334-47a9-b35f-54ce62f5bf99?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki musujące",
  "source": "urpl",
  "strength": "500 mg + 30 mg",
  "packaging": "05909991456337 ¦ Rp ¦ 140613\n16 tabl.",
  "substance": "Paracetamolum 500 mg + Codeini phosphas hemihydricus 30 mg",
  "common_name": "Paracetamolum + Codeini phosphas hemihydricus",
  "pl_product_id": "100453519",
  "pozwolenie_nr": "209/21",
  "auth_procedure": "IR",
  "authorisation_validity": "2031-06-14"
}

See everything about codein, kombinationen exkl. psycholeptika (codein monopräparate siehe r05da04).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.